The Impact of Genotype on Plasma and Cerebral Spinal Fluid Pharmacokinetics of Celecoxib in Children

Trial Profile

The Impact of Genotype on Plasma and Cerebral Spinal Fluid Pharmacokinetics of Celecoxib in Children

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Procedural pain
  • Focus Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 17 Aug 2016 Planned End Date changed from 1 Jan 2017 to 1 Aug 2017.
    • 17 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 May 2017.
    • 17 Aug 2016 Planned initiation date changed from 1 Apr 2016 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top